Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for pembrolizumab combined with palliative radiation is displayed, including study details, participation criteria, results measures, record dates, and study documents.SummaryDifference58%

- Check9 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide notice announces that NIH is transitioning to use “Super Intelligence” in place of “Artificial Intelligence,” with links to updates and FAQs.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label updates from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study details. This indicates an access issue rather than updates to the study content or structure.SummaryDifference20%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.